Breaking News Instant updates and real-time market news.

FB

Facebook

$176.27

-1.18 (-0.66%)

, WMT

Walmart

$96.10

1.58 (1.67%)

07:35
08/29/18
08/29
07:35
08/29/18
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Tuesday in Facebook (FB), Wal-Mart (WMT), Caesars (CZR), Campbell Soup (CPB), Itau Unibanco (ITUB), Corning (GLW), Workday (WDAY), Juniper (JNPR), Restoration Hardware (RH), and AstraZeneca (AZN).

FB

Facebook

$176.27

-1.18 (-0.66%)

WMT

Walmart

$96.10

1.58 (1.67%)

CZR

Caesars

$10.43

0.025 (0.24%)

CPB

Campbell Soup

$39.83

-0.87 (-2.14%)

ITUB

Itau Unibanco

$10.35

-0.175 (-1.66%)

GLW

Corning

$33.67

0.04 (0.12%)

WDAY

Workday

$152.39

0.71 (0.47%)

JNPR

Juniper

$28.92

0.36 (1.26%)

RH

RH

$159.20

5.68 (3.70%)

AZN

AstraZeneca

$38.65

0.05 (0.13%)

  • 29

    Aug

  • 30

    Aug

  • 04

    Sep

  • 04

    Sep

  • 05

    Sep

  • 05

    Sep

  • 06

    Sep

  • 06

    Sep

  • 06

    Sep

  • 07

    Sep

  • 12

    Sep

  • 12

    Sep

  • 18

    Sep

  • 27

    Sep

  • 02

    Oct

  • 16

    Oct

  • 28

    Oct

FB Facebook
$176.27

-1.18 (-0.66%)

08/22/18
08/22/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. SIDOTI UPGRADES SYSTEMAX TO BUY: Sidoti analyst Anthony Lebiedzinski upgraded Systemax (SYX) to Buy from Neutral. The analyst said the recent selloff in shares is overdone and maintained a $45 price target. Systemax shares are up 10.2% in morning trading. PIPER CUTS STARBUCKS TO NEUTRAL: Piper Jaffray analyst Nicole Miller Regan downgraded Starbucks (SBUX) last night to Neutral from Overweight and lowered her price target for the shares to $53 from $60. The motivation for the downgrade was another month of U.S. checks that suggested a lack of comp performance, Miller Regan said. The analyst believes shares of Starbucks will be "range bound at best" until U.S. trends improve. She sees issues around "inconsistent results, credibility of guidance, and management transitions." Miller Regan thinks the stock has "modest downside risk." MKM BOOSTS NETFLIX TARGET TO $395: MKM Partners analyst Rob Sanderson raised his price target for Netflix (NFLX) to $395 from $390 and kept a Buy rating on the shares after updating his estimates. The analyst said his "previous caution" on the shares is "now reversed" following the recent stock price correction. His subscriber ramp expectations are "somewhat lower" in the near-to-medium term but remain unchanged in the long-term. Netflix will approach full penetration of the U.S. over time, growing to 90M subscribers by 2025, Sanderson said. He continues to see over $40 per share in earnings power at 90M U.S. and 300M international subscribers, which he projected in the 2025 timeframe. Expectations for Netflix became "somewhat elevated, but have been appropriately moderated," Sanderson contended. He called the stock a "must-own for growth managers." BAIRD SAYS STAR WARS LICENSE ADDS VISIBILITY FOR ZYNGA: Baird analyst Colin Sebastian believes the Star Wars license announced adds some visibility to Zynga's (ZNGA) out-year growth targets. The new Disney (DIS) license is a positive development for Zynga for the longer-term given the popularity of the Star Wars franchise, Sebastian said. That said, he does not expect a material contribution from new titles until 2020. As such, Sebastian kept a Neutral rating on Zynga shares. Znga shares are up 7.6% in late morning trading. PIPER SAYS FACEBOOK USERS 'UNFAZED' BY ISSUES: Piper Jaffray analyst Michael Olson said his firm's survey of 1,300 Facebook (FB) and Instagram users leaves him confident that "most are unfazed by the negative news flow." The analyst kept an Overweight rating on Facebook shares with a $200 price target.
08/17/18
PIVT
08/17/18
NO CHANGE
Target $140
PIVT
Sell
Facebook suit, Burma issues point to 'systemic problems,' says Pivotal Research
Pivotal Research analyst Brian Wieser noted that a lawsuit was filed on Wednesday by one of Facebook's small business advertisers that alleges, citing anonymous former employees, that "those who were responsible for ensuring the accuracy of the Potential Reach at Facebook were indifferent to the actual numbers." He also noted that the United Nations has "accused Facebook of playing a determining role in stirring up hatred against the Rohingya Muslim minority in Rakhine State" of Burma. Both the lawsuit related to Ads Manager reach data and the recent reporting on how Facebook ignored concerns related to its role in the problems in Burma "further illustrate systemic problems with the company," contends Wieser, who keeps a $140 price target and Sell rating on Facebook shares.
08/22/18
PIPR
08/22/18
NO CHANGE
Target $200
PIPR
Overweight
Piper survey shows most Facebook, Instagram users unfazed by recent issues
Piper Jaffray analyst Michael Olson says his firm's survey of 1,300 Facebook and Instagram users leaves him confident that "most are unfazed by the negative news flow." Facebook has had a rough year from a public relations perspective, with Cambridge Analytica, concern around "fake news" and privacy issues, Olson tells investors in a research note. However, the survey, which focused on usage of the services this year versus last year, found that the majority, or two-thirds, are using Facebook and Instagram the same or more versus last year, Olson writes. He believes the 21% pullback in Facebook shares since the July 25 close more than reflects issues surrounding Europe's new privacy laws as well as the rising cost of content security and screening. The analyst keeps an Overweight rating on Facebook shares with a $200 price target. The social media giant closed yesterday up 12c to $172.62.
08/21/18
LSCM
08/21/18
NO CHANGE
Target $4
LSCM
Buy
Sito Mobile price target lowered to $4 from $9 at Lake Street
Lake Street analyst Mark Argento blames Sito Mobile (SITO) management for misjudging the time it has taken to close deals, but he believes they have the right long-term vision and need to maximize the long-term opportunity while acknowledging "near-term realities," including the fact that Facebook (FB) data issues have touched off significant introspection by potential customers. He lowered his price target on the stock to $4 from $9 to reflect the continued push out of big data wins and uncertainty surrounding the legacy media placement business. While he now thinks Sito is "firmly in show-me territory," Argento keeps a Buy rating on the shares.
WMT Walmart
$96.10

1.58 (1.67%)

08/20/18
BERN
08/20/18
NO CHANGE
BERN
Bernstein concerned about Walmart's online growth
Bernstein analyst Brandon Fletcher says that while Walmart had a great sales performance and raised guidance, he is concerned about the economics of the online growth as he believes pick from store is the least efficient method. The analyst thinks Walmart's engineering teams have come to the same conclusion, but the behavior of rolling pickup to1800 stores and 40% of U.S. geography getting grocery delivery without new supply chain assets is incongruent. Furthermore, Fletcher is "bewildered" by the curious incident of the 4.5% comp in the Walmart nighttime. While Walmart's price leadership stance is clear with softer margins, the analyst is not sensing the deep price cuts of the past.
08/28/18
MKMP
08/28/18
NO CHANGE
Target $117
MKMP
Buy
Dollar General price target raised to $117 from $107 at MKM Partners
MKM Partners analyst Patrick McKeever raised his price target on Dollar General (DG) to $117 and kept his Buy rating as part of his broader research note on the discount retail sector. The analyst notes that he is watching the Farm Bill and its impact on food stamp assistance as it relates to the lower-income consumers, but still believes that the macro backdrop for that sector is good as evidenced by Walmart's (WMT) 4.5% Q1 comp growth. McKeever prefers Dollar General to Neutral-rated Dollar Tree (DLTR) given its "ongoing execution issues and lagging productivity". The analyst adds that he is positive on Dollar General's store economics after the company opened a record number of stores last year and grew its square footage by 9%, which is "one of the highest rates in retail".
08/27/18
MSCO
08/27/18
NO CHANGE
MSCO
Equal Weight
Walmart battle with Amazon set to escalate, says Morgan Stanley
Morgan Stanley analyst Simeon Gutman believes Walmart's (WMT) battle with Amazon (AMZN) is about to intensify and he views its ability to counter Amazon's challenges as the key long-term debate on the stock. He believes Walmart shares are pricing in a continuation of 2-3% comps over the next few years with 40% e-commerce growth and improving e-commerce profitability, but he fears this may not be sustainable. He keeps an Equal Weight rating on Walmart shares, stating that to make him more bullish Walmart needs to show sustained top-line strength in both channels and to become more bearish he'd have to see U.S. EBIT margins contract more than he expects.
08/21/18
MKMP
08/21/18
NO CHANGE
Target $107
MKMP
Neutral
MKM Partners lowers Walmart EPS target on confirmed majority Flipkart stake
MKM Partners analyst Patrick McKeever kept his $107 price target and Neutral rating on Walmart but lowered his FY18 EPS view by 25c and FY19 EPS view by 60c to $4.75 for both years after the company announced its closed agreement to become the largest shareholder in India's Flipkart. The analyst adds that the dilution-related losses from the Flipkart deal should decline in the medium to long term while returns improve. McKeever further states that his model update reflects some adjustments made following the sale of an 80% stake in Walmart Brazil to Advent.
CZR Caesars
$10.43

0.025 (0.24%)

08/21/18
NOMU
08/21/18
NO CHANGE
NOMU
Buy
Room survey suggests 'modest' upside to guidance for MGM, Caesars, says Nomura
Nomura Instinet analyst Harry Curtis said in a research note to investors that while his latest Las Vegas room rate survey shows "mostly negative" y/y trends through October, sequential price momentum, measured by first-to-last call rates, has become more positive for Strip operators for the first time in months. Curtis says the latest survey for Q3 shows y/y rates down 1.2% for MGM (MGM) vs. guidance of down 5%-7% and up 3.6% for Caesars (CZR) vs. guidance of flat to up 2%, suggesting there could be modest upside to Q3 guidance for both MGM and Caesars. The analyst has a Buy rating on both stocks.
06/19/18
OPCO
06/19/18
NO CHANGE
Target $15
OPCO
Outperform
Caesars runway for growth remains strong, says Oppenheimer
Oppenheimer analyst Ian Zaffino said Caesars management sees significant upside from the legalization of sports betting, though they note the ramp could be mild. Management also remains confident Caesars can deliver above-market RevPAR growth and near-industry-leading margins. Following his management meetings, Zaffino remains bullish on Caesars and maintains an Outperform rating and $15 price target on the shares.
07/23/18
BOFA
07/23/18
INITIATION
Target $14
BOFA
Buy
Caesars initiated with a Buy at BofA/Merrill
BofA/Merrill analyst Shaun Kelley initiated Caesars with a Buy and $14 price target. Kelley is positive on Caesars internal growth opportunities, including room renovations and cost optimization, the favorable backdrop for both Vegas and regional gaming, and continued M&A in the sector.
05/24/18
05/24/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Broadcom (AVGO) initiated with an Outperform at Evercore ISI. 2. Caesars (CZR) initiated with an Overweight at JPMorgan. 3. e.l.f. Beauty (ELF) initiated with an Outperform at Oppenheimer. 4. uniQure (QURE) initiated with a Buy at SunTrust. 5. Marinus Pharmaceuticals (MRNS) initiated with an Outperform at Baird. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
CPB Campbell Soup
$39.83

-0.87 (-2.14%)

08/23/18
RBCM
08/23/18
NO CHANGE
Target $43
RBCM
Sector Perform
Campbell Soup price target raised to $43 from $40 at RBC Capital
RBC Capital analyst David Palmer raised his price target on Campell Soup to $43 ahead of its FY19 guidance and strategic review on the assumption of a more aggressive overhead rationalization and announcement of "credible action" to stabilize its core soup business. The analyst also lowers his FY19 EPS view to $2.68 from $2.78 to reflect rising cost pressures and recent sales trend, but boosts his "upside scenario" profit target to $55 to account for the possibility of strategic alternatives. Palmer keeps his Sector Perform rating on Campbell Soup.
08/23/18
UBSW
08/23/18
NO CHANGE
Target $30
UBSW
Sell
Campbell Soup downside risk elevated ahead of strategic review, says UBS
UBS analyst Steven Strycula said his portfolio analysis agrees with the premise that a sale of Campbell Soup would be an immediate catalyst to create shareholder value. However, he believes the Board and family do not want to sell and instead would prefer to divest non-core assets and reduce debt. The analyst believes downside risk in the shares will be elevated ahead of the strategic review presentation on August 30. Strycula reiterated his Sell rating and $30 price target on Campbell Soup shares.
08/14/18
PIPR
08/14/18
NO CHANGE
Target $35
PIPR
Underweight
Piper views sale of Campbell Soup as unlikely
Piper Jaffray analyst Michael Lavery does not expect a sale of Campbell Soup (CPB) to be part of its strategic update. Rather, the analyst thinks the company will focus on how it can turn around its business. He believes spending increases are needed and that a C-Fresh divestiture is likely, but with only modest proceeds. He thinks Kraft Heinz (KHC), viewed as a potential bidder if Campbell Soup were for sale, "prefers brands with stronger equity and market share positions and may not be interested." Lavery lowered his price target for Campbell shares to $35 from $36 and keeps an Underweight rating on the name.
08/20/18
WELS
08/20/18
NO CHANGE
Target $42
WELS
Market Perform
Campbell Soup price target raised to $42 from $34 at Wells Fargo
Wells Fargo analyst John Baumgartner raised his price target for Campbell Soup to $42 from $34 as he weighs strategic options for the company. Ahead of the company's strategic review and Q4 EPS, the analyst concludes that with proper execution, U.S. soup can be stabilized and in time Campbell can achieve its long-term growth rates, portfolio adjustments should include the divestitures of C-Fresh and Asian Global Baking & Snacking, and a sale of Campbell Soup at this time is unlikely to maximize fair value. Baumgartner reiterates a Market Perform rating on the shares.
ITUB Itau Unibanco
$10.35

-0.175 (-1.66%)

12/11/17
DBAB
12/11/17
UPGRADE
Target $16
DBAB
Buy
Itau Unibanco upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Tito Labarta upgraded Itau Unibanco to Buy and raised his price target for the shares to $16 from $11. After spending time in Brazil, the analyst has increased confidence that the economy is recovering. Labarta likes Itau's excess capital, high coverage ratio and "strong" dividend yield.
06/05/18
SBSH
06/05/18
UPGRADE
SBSH
Buy
Itau Unibanco upgraded to Buy from Neutral at Citi
03/05/18
FBCO
03/05/18
UPGRADE
FBCO
Outperform
Itau Unibanco upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Marcelo Telles upgraded Itau Unibanco to Outperform and raised his price target for the shares to R$60 from R$48. The analyst views the company as well positioned for the credit cycle and believes its earnings momentum will be stronger than expected.
03/14/18
SCOT
03/14/18
DOWNGRADE
SCOT
Underperform
Itau Unibanco downgraded to Underperform from Sector Perform at Scotiabank
GLW Corning
$33.67

0.04 (0.12%)

05/31/18
05/31/18
UPGRADE
Target $34

Overweight
Corning upgraded to Overweight amid 'overdone' display worries at Morgan Stanley
As previously reported, Morgan Stanley analyst James Faucette upgraded Corning to Overweight from Equal Weight, stating that the number one question he gets from investors is about how the display market has remained so healthy despite weakness in the panel market over the past couple of years. The analyst, who thinks concerns over the display segment have been "overdone," notes supply and demand are more in unison, the company maintains a cost advantage, and Corning dominates where the display market is healthiest. He also contends that expansion opportunities are closer than they appear as he believes there will be demonstrated traction in one, if not multiple, of Corning's areas of investment in the coming years. Faucette raised his price target on Corning shares to $34 from $33.
06/20/18
GSCO
06/20/18
UPGRADE
Target $29
GSCO
Neutral
Corning upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Rod Hall assumed coverage of Corning with an upgrade to Neutral from Sell and a price target of $29. The analyst expects gross margin deterioration to reverse.
05/31/18
MSCO
05/31/18
UPGRADE
MSCO
Overweight
Corning upgraded to Overweight from Equal Weight at Morgan Stanley
05/31/18
05/31/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Motors (GM) upgraded to Outperform from In Line at Evercore ISI with analyst George Galliers saying he had been assigning no value to the Cruise assets before the announcement. 2. Biogen (BIIB) upgraded to Buy from Hold at Canaccord with analyst Sumant Kulkarni saying although there are risks that remain, the company's financial flexibility makes him more positive on the shares. 3. Corning (GLW) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst James Faucette saying that the number one question he gets from investors is about how the display market has remained so healthy despite weakness in the panel market over the past couple of years. 4. Quality Systems (QSII) upgraded to Overweight from Neutral at Cantor Fitzgerald with analyst Steven Halper saying after the better than expected Q4 results, it appears the company's growth prospects have improved. 5. Extended Stay America (STAY) upgraded to Overweight at Morgan Stanley with analyst Thomas Allen noting that company management highlighted at a recent conference that it could follow a similar path to La Quinta (LQ), which recently announced plans to shift from an asset-heavy, single-brand Lodging company to a REIT. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
WDAY Workday
$152.39

0.71 (0.47%)

08/20/18
GUGG
08/20/18
INITIATION
Target $175
GUGG
Buy
Workday initiated with a Buy at Guggenheim
As reported earlier, Guggenheim analyst Nandan Amladi initiated Workday with a Buy rating and a price target of $175 as part of a broader research note on Human Capital Management software makers. The analyst sees Workday as his "Top Idea" in the space, saying that its product provides a "platform for long-term growth" in the Global 2000 and its management is "most tenured" in scaling businesses. Amladi believes that Workday has a "long runway for sustained growth in profitability", reaching $10B in revenue as soon as 2025.
08/24/18
OTRG
08/24/18
UPGRADE
OTRG
Positive
Workday upgraded to Positive from Mixed at OTR Global
08/23/18
RBCM
08/23/18
NO CHANGE
Target $159
RBCM
Outperform
Workday price target raised to $159 from $154 at RBC Capital
RBC Capital analyst Ross MacMillan raised his price target on Workday to $159 and kept his Outperform rating ahead of its Q2 earnings, saying the company should post re-accelerated billings growth and a beat and raise on subscription revenue. MacMillan also notes that Workday's Adaptive Insights acquisition may result in a lower FY19 guidance for operating margins and free cash flow, but the deal should turn accretive to earnings by FY21. The analyst further points to the company's "stable" hiring data and short interest.
08/20/18
GUGG
08/20/18
INITIATION
Target $175
GUGG
Buy
Workday initiated with a Buy at Guggenheim
Guggenhein analyst initiated Workday with a Buy rating and a price target of $175.
JNPR Juniper
$28.92

0.36 (1.26%)

07/30/18
DBAB
07/30/18
UPGRADE
Target $32
DBAB
Buy
Juniper upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Vijay Bhagavath upgraded Juniper Networks to Buy and raised his price target for the shares to $32 from $25.
07/30/18
DBAB
07/30/18
UPGRADE
Target $32
DBAB
Buy
Deutsche makes 'contrarian call' on Juniper, upgrades shares to Buy
Deutsche Bank analyst Vijay Bhagavath upgraded Juniper Networks to Buy from Hold and raised his price target for the shares to $32 from $25. The stock closed Friday down 7%, or $2.08, to $26.18. The analyst says he's "going against the grain" and making a "contrarian call." The post-earnings selloff on the "better than feared" Q2 results and below consensus Q3 guidance, which is primarily related to switch router upgrade timing at a handful of cloud and service provider customers, provides a "reasonable entry point," Bhagavath tells investors in a research note. He believes "robust" switch router and next generation security refresh cycles will start in fiscal 2019 and that Juniper's fundamentals will improve from fiscal 2019 through fiscal 2021.
07/30/18
07/30/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AT&T (T) upgraded to Buy from Neutral at BofA/Merrill with analyst David Barden saying he is positive on AT&T's 20-year low P/E multiple, Timer Warner (TWX) merger benefits of earnings accretion and expanding cash, favorable emerging wireless business trends, and a call option on value extraction from the merger of AT&T's distribution network with Time Warner's content and ad inventory. 2. American Airlines (AAL) upgraded to Outperform from Neutral at Macquarie. 3. Avis Budget (CAR) upgraded to Buy from Neutral at Northcoast. 4. Cabot Oil & Gas (COG) upgraded to Positive from Neutral at Susquehanna with analyst Biju Perincheril citing the recent weakness in the shares but he also feels the risk/reward is attractive with many projects providing production growth over the next two years along with accelerating free cash flow generation. 5. Juniper (JNPR) upgraded to Buy from Hold at Deutsche Bank with analyst Vijay Bhagavath saying he's "going against the grain" and making a "contrarian call." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/30/18
07/30/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. BOFA UPGRADES AT&T TO BUY: Bank of America Merrill Lynch upgraded AT&T (T) to Buy from Neutral as analyst David Barden is positive on AT&T's 20-year low P/E multiple, Timer Warner merger benefits, favorable emerging wireless business trends, and a call option on value extraction from the merger of AT&T's distribution network with Time Warner's content and ad inventory. He keeps a $37 price target on AT&T shares. DEUTSCHE UPS JUNIPER IN 'CONTRARIAN' CALL: Deutsche Bank analyst Vijay Bhagavath upgraded Juniper Networks (JNPR) to Buy from Hold and raised his price target for the shares to $32 from $25. The analyst said he's "going against the grain" and making a "contrarian call." The post-earnings selloff on the "better than feared" Q2 results and below consensus Q3 guidance, which is primarily related to switch router upgrade timing at a handful of cloud and service provider customers, provides a "reasonable entry point." He believes "robust" switch router and next generation security refresh cycles will start in fiscal 2019 and that Juniper's fundamentals will improve from FY19 through FY21. STIFEL CUTS SYNCHRONOS TO SELL: Stifel analyst Tom Roderick downgraded Synchronoss (SNCR) to Sell from Hold, stating that recent filings reveal that liquidity issues loom, the company is "out of levers, and time is not on their side." The turnaround required to keep the company from fundraising "feels Herculean," added Roderick, who lowered his price target on Synchronoss shares to $3 from $8. BUCKINGHAM SAYS FORCED SALE OF CHARTER ASSETS 'UNLIKELY': Buckingham analyst Matthew Harrigan noted that New York's Public Service Commission has moved to push Charter (CHTR) out of the state and presented the company with a 60 day ultimatum to find a buyer for its assets there due to what it views as "repeated failures" to honor its commitments around the 2016 merger with Time Warner Cable. While he thinks an extended court battle seems "virtually certain," Harrigan does not see much likelihood of any forced disposition of its New York State assets. He keeps a Buy rating and $397 price target on Charter shares.
RH RH
$159.20

5.68 (3.70%)

07/03/18
LOOP
07/03/18
NO CHANGE
Target $175
LOOP
Buy
RH price target raised to $175 from $160 at Loop Capital
Loop Capital analyst Anthony Chukumba raised his price target on RH to $175 and kept his Buy rating, citing the company's ability to issue debt with no cash interest cost after the completion of its $335M convertible note offering. The analyst says this shows investors' confidence in RH's long term growth prospects, assigning a higher PE multiple in his model to account for increased market bullishness. Chukumba adds that RH is trading at 20.1-times this year's expected earnings, which is a discount to its historical average levels.
08/29/18
LOOP
08/29/18
NO CHANGE
Target $175
LOOP
Buy
RH Q2 may outperform after strong Williams-Sonoma results, says Loop Capital
Loop Capital analyst Anthony Chukumba kept his Buy rating and $175 price target on RH (RH) ahead of its Q2 earnings next week, saying the better than expected results in the quarter from Williams-Sonoma (WSM) is a positive harbinger for the company. The analyst expects investors to focus on RH's "comparable brand revenue growth, Q3 guidance, recent senior executive departures, and early results from the recently opened next-generation design galleries".
08/28/18
GDHS
08/28/18
UPGRADE
GDHS
Accumulate
RH upgraded to Accumulate from Hold at Gordon Haskett
08/28/18
08/28/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. RH (RH) upgraded to Accumulate from Hold at Gordon Haskett. 2. Estee Lauder (EL) and Coty (COTY) upgraded to Overweight from Equal Weight at Morgan Stanley. 3. First Business Financial (FBIZ) upgraded to Buy from Neutral at DA Davidson with analyst Kevin Reevey saying the current trading level on the stock presents an attractive entry point after its 10% month-to-date decline and a 19% retreat from its 52-week highs. 4. Regency Centers (REG) upgraded to Buy from Hold at Deutsche Bank with analyst Derek Johnston saying "clear signs" of a retail recovery has fueled the rally in strip real estate investment trusts in recent weeks. 5. Affimed N.V. (AFMD) upgraded to Buy from Hold at Jefferies with analyst Maury Raycroft saying its collaboration with Roche Group's (RHHBY) Genentech to develop and commercialize novel NK cell engagers indicate the intrinsic value in Affimed's platform and approach. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
AZN AstraZeneca
$38.65

0.05 (0.13%)

08/08/18
HCWC
08/08/18
NO CHANGE
Target $43
HCWC
Buy
Insmed likely to be acquired after positive panel vote, says H.C. Wainwright
H.C. Wainwright analyst Andrew Fein raised his price target for Insmed (INSM) to $43 from $35 following yesterday's 12-2 FDA panel vote in favor of ALIS in refractory nontuberculous mycobacterial patients. Insmed is now likely to be acquired as ALIS "fits well within the pipeline of a number of larger companies," Fein tells investors in a research note. He expects the company's Q3 conference call "may well be its last." The analyst sees AstraZeneca (AZN), Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX) as potential acquirers of Insmed. He reiterates a Buy rating on Insmed.
08/16/18
08/16/18
DOWNGRADE

Hold
AstraZeneca downgraded to Hold following outperformance at Jefferies
As previously reported, Jefferies analyst Ian Hilliker downgraded AstraZeneca (AZN) to Hold from Buy citing valuation following the stock's outperformance since he upgraded it in March. Hilliker has raised his price target on AstraZeneca to 6,200p, but notes that this only leaves about 8% of further upside. Following results for the Q2 period, Hilliker said Novartis (NVS) remains his top European Pharmaceuticals pick, followed by Roche (RHHBY) and GlaxoSmithKline (GSK) in third place.
08/16/18
JEFF
08/16/18
DOWNGRADE
JEFF
Hold
AstraZeneca downgraded to Hold from Buy at Jefferies
08/16/18
08/16/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AstraZeneca (AZN) downgraded to Hold from Buy at Jefferies with analyst Ian Hilliker citing valuation following the stock's outperformance since he upgraded it in March. 2. Cemex (CX) downgraded to Hold from Buy at HSBC with analyst Eduardo Altamirano saying Cemex's deleveraging remains intact, but the pace at which debt is converted to equity is slowing down due to weaker than expected pricing and volumes in most regions, combined with higher input costs. 3. Cenovus Energy (CVE) downgraded to Hold from Buy at Canaccord with analyst Dennis Fong saying cash flow valuation is in line versus the large-cap group, which he thinks is appropriate given the company's above-average heavy oil exposure, moderated production growth profile, and higher leverage. 4. Nanometrics (NANO) downgraded to Neutral from Buy at DA Davidson with analyst Thomas Diffely saying that after outperforming its peer group over the past few years, the stock now trades at a 40% premium to its peers. 5. Coty (COTY) downgraded to Underperform from Buy at BofA/Merrill with analyst Olivia Tong citing inconsistent execution and increasing disruption across the mass beauty segment. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

02:10
09/26/18
09/26
02:10
09/26/18
02:10
General news
FX Action: USD-JPY traded above 113.00 »

FX Action: USD-JPY traded…

01:40
09/26/18
09/26
01:40
09/26/18
01:40
General news
Asian Market Wrap: »

Asian Market Wrap:…

KKR

KKR

$28.12

-0.13 (-0.46%)

21:13
09/25/18
09/25
21:13
09/25/18
21:13
Hot Stocks
KKR forms management company to provide health care services in China »

KKR announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

A

Agilent

$70.38

0.43 (0.61%)

21:11
09/25/18
09/25
21:11
09/25/18
21:11
Hot Stocks
Agilent acquires ACEA Bioscience for $250M in cash »

Agilent Technologie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

EQM

EQT Midstream Partners

$52.64

-2.16 (-3.94%)

20:58
09/25/18
09/25
20:58
09/25/18
20:58
Recommendations
EQT Midstream Partners analyst commentary at MUFG »

EQT Midstream Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FPAY

FlexShopper

$1.16

-0.69 (-37.30%)

20:42
09/25/18
09/25
20:42
09/25/18
20:42
Syndicate
FlexShopper 10M unit Secondary priced at $1.00 »

acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

IGC

IGC, Inc

$2.32

-0.22 (-8.66%)

20:40
09/25/18
09/25
20:40
09/25/18
20:40
Hot Stocks
IGC to enter Hemp/CBD-infused energy drink space »

India Globalization…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAL

Delta Air Lines

$57.10

-0.33 (-0.57%)

20:32
09/25/18
09/25
20:32
09/25/18
20:32
Periodicals
Breaking Periodicals news story on Delta Air Lines »

Delta Air Lines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

SPY

SPDR S&P 500 ETF Trust

$290.73

-0.36 (-0.12%)

, SPX

S&P 500

$0.00

(0.00%)

20:32
09/25/18
09/25
20:32
09/25/18
20:32
Periodicals
Trump considering keeping Deputy AG Rosenstein, WSJ says »

Donald Trump has…

SPY

SPDR S&P 500 ETF Trust

$290.73

-0.36 (-0.12%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARCE

Arco Platform

$0.00

(0.00%)

20:31
09/25/18
09/25
20:31
09/25/18
20:31
Syndicate
Arco Platform 11.111M share IPO priced at $17.50 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

KMX

CarMax

$75.87

-0.01 (-0.01%)

20:25
09/25/18
09/25
20:25
09/25/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 06

    Nov

AINC

Ashford

$75.95

-11.75 (-13.40%)

20:23
09/25/18
09/25
20:23
09/25/18
20:23
Syndicate
Ashford 270K share Secondary priced at $74.50 »

UBS, RBC Capital and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 26

    Sep

ANAB

AnaptysBio

$94.68

-7.25 (-7.11%)

20:21
09/25/18
09/25
20:21
09/25/18
20:21
Syndicate
AnaptysBio 2.2M share Secondary priced at $94.46 »

Credit Suisse, JPMorgan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

SF

Stifel Financial

$53.96

-0.08 (-0.15%)

20:01
09/25/18
09/25
20:01
09/25/18
20:01
Hot Stocks
Stifel Financial and Everbright Sun Hung Kai establish strategic partnership »

Stifel Financial and Hong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

I

Intelsat

$27.08

4.365 (19.22%)

19:59
09/25/18
09/25
19:59
09/25/18
19:59
Hot Stocks
Intelsat and Azercosmos announce successful satellite launch »

Intelsat S.A. and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKY

Skyline

$30.88

0.66 (2.18%)

19:49
09/25/18
09/25
19:49
09/25/18
19:49
Hot Stocks
Breaking Hot Stocks news story on Skyline »

Centerbridge Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

KBH

KB Home

$25.29

-0.24 (-0.94%)

, AIR

AAR Corp.

$46.03

1.04 (2.31%)

19:28
09/25/18
09/25
19:28
09/25/18
19:28
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: KB…

KBH

KB Home

$25.29

-0.24 (-0.94%)

AIR

AAR Corp.

$46.03

1.04 (2.31%)

VSTM

Verastem

$7.15

-1.74 (-19.57%)

CGIX

Cancer Genetics

$1.22

-0.01 (-0.81%)

VNDA

Vanda Pharmaceuticals

$20.70

0.3 (1.47%)

NLSN

Nielsen

$27.21

0.055 (0.20%)

CYH

Community Health

$3.41

-0.08 (-2.29%)

AUPH

Aurinia Pharmaceuticals

$5.89

0.02 (0.34%)

GOOS

Canada Goose

$58.00

-0.04 (-0.07%)

ABBV

AbbVie

$93.78

0.34 (0.36%)

NKE

Nike

$84.79

0.52 (0.62%)

CTAS

Cintas

$212.99

1.81 (0.86%)

LULU

Lululemon

$158.42

1.04 (0.66%)

CONE

CyrusOne

$64.65

-0.6 (-0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 01

    Oct

  • 02

    Oct

  • 04

    Oct

  • 05

    Oct

  • 26

    Sep

CBS

CBS

$56.54

-0.07 (-0.12%)

19:19
09/25/18
09/25
19:19
09/25/18
19:19
Hot Stocks
CBS names Richard Parsons interim chairman »

Richard Parsons has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

ZUMZ

Zumiez

$27.00

-0.55 (-2.00%)

19:09
09/25/18
09/25
19:09
09/25/18
19:09
Initiation
Zumiez initiated at DA Davidson »

Zumiez initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROST

Ross Stores

$97.54

0.26 (0.27%)

, TJX

TJX

$110.33

0.605 (0.55%)

19:03
09/25/18
09/25
19:03
09/25/18
19:03
Initiation
Ross Stores, TJX initiated at DA Davidson »

Ross Stores initiated…

ROST

Ross Stores

$97.54

0.26 (0.27%)

TJX

TJX

$110.33

0.605 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MNOV

MediciNova

$11.68

-0.17 (-1.43%)

19:01
09/25/18
09/25
19:01
09/25/18
19:01
Hot Stocks
MediciNova announces 'positive' FDA feedback on Phase 3 plan for MN-166 »

MediciNova announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVH

PVH Corp.

$140.00

-0.56 (-0.40%)

18:58
09/25/18
09/25
18:58
09/25/18
18:58
Initiation
PVH Corp. initiated at DA Davidson »

PVH Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 03

    Oct

GOOS

Canada Goose

$58.00

-0.04 (-0.07%)

18:50
09/25/18
09/25
18:50
09/25/18
18:50
Initiation
Canada Goose initiated at DA Davidson »

Canada Goose initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PM

Philip Morris

$79.91

-0.55 (-0.68%)

18:47
09/25/18
09/25
18:47
09/25/18
18:47
Periodicals
Philip Morris hits streets to sell older smokers on new devices, Bloomberg says »

Philip Morris is moving a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

URBN

Urban Outfitters

$40.06

-0.32 (-0.79%)

18:45
09/25/18
09/25
18:45
09/25/18
18:45
Initiation
Urban Outfitters initiated at DA Davidson »

Urban Outfitters…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.